FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlamar Biosciences, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALMR
Alamar Biosciences, Inc. Stock AnalysisComprehensive stock analysis for Alamar Biosciences, Inc. (ALMR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALMR
ALMR
Alamar Biosciences, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALMR
  1. Home
  2. Stocks
  3. Alamar Biosciences, Inc.

Alamar Biosciences, Inc.

🇺🇸ALMR•NASDAQ

Alamar Biosciences, Inc.

🇺🇸ALMR•NASDAQ
Market cap
$2.12B
Sentiment

Your view on ALMR

Mkt Cap
$2.12B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alamar Biosciences, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Yuling Luo
Headquarters
47071 Bayside Parkway, Fremont, CA, US
Industry
Biotechnology
Sector
Healthcare
CEO
Yuling Luo
Headquarters
47071 Bayside Parkway, Fremont, CA, US
Description

Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications.

Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Alamar Biosciences, Inc. from FRC's valuation model, read against the market price. ALMR last traded at $30.51; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Alamar Biosciences, Inc.. Starting points for Alamar Biosciences, Inc.: EPS -$0.80, beta -6.18 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Alamar Biosciences, Inc.. Alamar Biosciences, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Alamar Biosciences, Inc.. Trailing twelve-month EPS for Alamar Biosciences, Inc. stands at -$0.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Alamar Biosciences, Inc.. Alamar Biosciences, Inc. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ALMR12 companies

More Biotechnology companies

Market cap

  • ARUXFAcrux LimitedOTC$2M
  • ARVNArvinas, Inc.NASDAQ$443M
  • ARWRArrowhead Pharmaceuticals, Inc.NASDAQ$6.1B
  • ASBPAspire Biopharma Holdings, Inc.NASDAQ$910,285
  • ASBPWAspire Biopharma Holdings, Inc.NASDAQ$121,920
  • ASCLFAscletis Pharma Inc.OTC$2.1B
  • ASEP.CNAsep Medical Holdings IncCNQ
  • ASMBAssembly Biosciences, Inc.NASDAQ$458M
  • ASNDAscendis Pharma A/SNASDAQ$17.7B
  • ASPHFAscentage Pharma Group InternationalOTC$3.2B
  • ATAIAtai Life Sciences N.V.NASDAQ$2.7B
  • ATGGFActinogen Medical LimitedOTC$108M
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Alamar Biosciences, Inc., and how their positions are changing. At a $2.12B market value, institutional positions materially move Alamar Biosciences, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Alamar Biosciences, Inc. executives and directors. Shares of Alamar Biosciences, Inc. have traded between $18.85 and $29.43 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Alamar Biosciences, Inc.. Coverage tracks Alamar Biosciences, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Alamar Biosciences, Inc.

ALMR Analysis
Fair
Past5
Growth2
Health4
Profit1
Value1

News

Latest Market News